&nbsp;

Cancer101FlashCard-Alcohol-Metis

Sep 2018

Document

Cancer101FlashCard-HealthyWeight-Metis

Sep 2018

Document

Cancer101FlashCard-Prevention-Metis

Sep 2018

Document

Cancer101FlashCard-Stages-Metis

Sep 2018

Regimen

CISPGEMC(Q2W)

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Palliative

Drugs Used:

CISplatin,

gemcitabine

... Show more tags

Quick Link(s):

Regimen Monograph

May 2019

Regimen

CHOP+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

ODB - General Benefit

prednisone

Drugs Used:

Quick Link(s):

Regimen Monograph

Nov 2023

Regimen

CVP+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

ODB - General Benefit

prednisone

Drugs Used:

Quick Link(s):

Regimen Monograph

May 2019

Regimen

CVP(PO)+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

ODB - General Benefit

prednisone

ODB - General Benefit

cyclophosphamide - oral tablets

Drugs Used:

Quick Link(s):

Regimen Monograph

May 2019

Regimen

CHLO+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

ODB - General Benefit

chlorambucil

Drugs Used:

oBINutuzumab,

chlorambucil

... Show more tags

Quick Link(s):

Regimen Monograph

Dec 2018

Document

CapitalInvestmentStrategyExecutiveSummary.pdf

Nov 2018

Document